The Patent Finder

Theralase Technologies, Inc.

10 patents currently held · Updated Nov 16, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jan 2036
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 2, 2027
    The maintenance fee for Photodynamic Compounds and Methods for Activating Them Using Ionizing Radiation And/Or Other Electromagnetic Radiation for Therapy And/Or Diagnostics (US 10,335,608) comes due Jan 2, 2027. Unpaid by Jul 2, 2027, it lapses early.
  • 1 fee due Apr 24, 2027
    The maintenance fee for Method for treating conditions associated with hyperproliferating cells comprising combined administration of a cannabinoid receptor agonist and radiation therapy (US 11,793,818) comes due Apr 24, 2027. Unpaid by Oct 25, 2027, it lapses early.
  • 1 fee due May 14, 2027
    The maintenance fee for Sonodynamic therapy using sonodynamically activated coordination complexes of transition metals as sensitizing agents (US 11,813,330) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
  • 1 fee due Jul 7, 2027
    The maintenance fee for Apparatus and method for multiwavelength photodynamic therapy (US 10,525,279) comes due Jul 7, 2027. Unpaid by Jan 7, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

PatentTitleStatus Expires Confidence
US 9,737,565Metal-glycoprotein complexes and their use as chemotherapeutic compounds
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,111,936Metal-glycoprotein complexes and photodynamic therapy of immune privileged sites with same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,525,279Apparatus and method for multiwavelength photodynamic therapy
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,335,608Photodynamic Compounds and Methods for Activating Them Using Ionizing Radiation And/Or Other Electromagnetic Radiation for Therapy And/Or Diagnostics
In force
 · High confidence
In forceHigh confidence
US 11,241,587Fiber Optic Light Delivery, Monitoring and Apparatus Therefor
In force
 · High confidence
In forceHigh confidence
US 11,793,818Method for treating conditions associated with hyperproliferating cells comprising combined administration of a cannabinoid receptor agonist and radiation therapy
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,464,798Vaccine containing cancer cells inactivated by photodynamic treatment with metal-based coordination complexes, and immunotherapy method using same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,311,190Apparatus and method for irradiating inside an object
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,721,854Inactivation of Pathogens Using Metal-Based Coordination Complexes, and Methods and Compositions for Treating and Preventing Microbial And/Or Viral Infections
In force
 · Medium confidence
In forceMedium confidence
US 11,813,330Sonodynamic therapy using sonodynamically activated coordination complexes of transition metals as sensitizing agents
In force
 · From the USPTO record
In forceFrom the USPTO record

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 1 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited